ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.
Contents
- L02AA Estrogens
- L02AB Progestogens
- L02AE Gonadotropin releasing hormone analogues
- L02BA Anti estrogens
- L02BB Anti androgens
- L02BG Aromatase inhibitors
- L02BX Other hormone antagonists and related agents
- References
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL02.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
L02AA Estrogens
L02AA01 Diethylstilbestrol L02AA02 Polyestradiol phosphate L02AA03 Ethinylestradiol L02AA04 FosfestrolL02AB Progestogens
L02AB01 Megestrol L02AB02 Medroxyprogesterone L02AB03 GestonoroneL02AE Gonadotropin-releasing hormone analogues
L02AE01 Buserelin L02AE02 Leuprorelin L02AE03 Goserelin L02AE04 Triptorelin L02AE05 HistrelinL02BA Anti-estrogens
L02BA01 Tamoxifen L02BA02 Toremifene L02BA03 FulvestrantL02BB Anti-androgens
L02BB01 Flutamide L02BB02 Nilutamide L02BB03 Bicalutamide L02BB04 EnzalutamideL02BG Aromatase inhibitors
L02BG01 Aminogluthetimide L02BG02 Formestane L02BG03 Anastrozole L02BG04 Letrozole L02BG05 Vorozole L02BG06 ExemestaneL02BX Other hormone antagonists and related agents
L02BX01 Abarelix L02BX02 Degarelix L02BX03 AbirateroneReferences
ATC code L02 Wikipedia(Text) CC BY-SA